PMID- 20452291 OWN - NLM STAT- MEDLINE DCOM- 20110321 LR - 20230526 IS - 1528-8447 (Electronic) IS - 1526-5900 (Print) IS - 1526-5900 (Linking) VI - 11 IP - 12 DP - 2010 Dec TI - Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat. PG - 1356-67 LID - 10.1016/j.jpain.2010.03.013 [doi] AB - The protein kinase mammalian target of rapamycin (mTOR) regulates mRNA translation and is inhibited by rapamycin. Signaling pathways involving mTOR are implicated in physiological and pathophysiological processes. We determined the spinal effects of the rapamycin analogue cell cycle inhibitor (CCI)-779 on neuronal responses and behavioral hypersensitivity in a model of persistent neuropathic pain. We also assessed the anatomical distribution of spinal mTOR signaling pathways. Specifically, we ligated rat spinal nerves L5 and L6 to produce a model of neuropathic pain. After confirming neuropathy with behavioral testing, we obtained in vivo single-unit extracellular stimulus-evoked recordings from deep dorsal horn spinal neurons. We applied CCI-779 spinally in electrophysiological and behavioral studies and assessed its effects accordingly. We also used immunohistochemistry to probe for mTOR signaling pathways in dorsal root ganglia (DRG) and the spinal cord. We found that spinally administered CCI-779 rapidly attenuated calibrated mechanically but not thermally evoked neuronal responses and mechanically evoked behavioral responses. Immunohistochemistry showed presence of mTOR signaling pathways in nociceptive-specific C-fiber DRG and in neurons of inner lamina II of the spinal cord. We conclude that alterations in the activity of spinal mTOR signaling pathways are crucial to the full establishment of spinal neuronal plasticity and behavioral hypersensitivity associated with nerve injury. PERSPECTIVE: This study is consistent with growing evidence implicating mTOR signaling pathways as important modulators of persistent pain, providing novel insights into the molecular mechanisms of pain maintenance and potential for novel approaches into treating chronic pain. CI - Copyright (c) 2010 American Pain Society. Published by Elsevier Inc. All rights reserved. FAU - Asante, Curtis O AU - Asante CO AD - Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK. curtisasante@gmail.com FAU - Wallace, Victoria C AU - Wallace VC FAU - Dickenson, Anthony H AU - Dickenson AH LA - eng GR - WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100508 PL - United States TA - J Pain JT - The journal of pain JID - 100898657 RN - 0 (Protein Kinase Inhibitors) RN - 624KN6GM2T (temsirolimus) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Animals MH - Behavior, Animal MH - Electrophysiology MH - Hyperalgesia/metabolism/physiopathology MH - Immunohistochemistry MH - Male MH - Neuralgia/*metabolism/physiopathology MH - Neuronal Plasticity/drug effects/*physiology MH - Peripheral Nervous System Diseases/*metabolism MH - Protein Kinase Inhibitors/pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Signal Transduction/drug effects/*physiology MH - Sirolimus/analogs & derivatives/pharmacology MH - Spinal Cord/drug effects/*metabolism/physiopathology MH - Spinal Nerves/drug effects/injuries/*metabolism MH - TOR Serine-Threonine Kinases/*metabolism PMC - PMC3000494 EDAT- 2010/05/11 06:00 MHDA- 2011/03/22 06:00 PMCR- 2010/12/01 CRDT- 2010/05/11 06:00 PHST- 2009/10/27 00:00 [received] PHST- 2010/03/04 00:00 [revised] PHST- 2010/03/16 00:00 [accepted] PHST- 2010/05/11 06:00 [entrez] PHST- 2010/05/11 06:00 [pubmed] PHST- 2011/03/22 06:00 [medline] PHST- 2010/12/01 00:00 [pmc-release] AID - S1526-5900(10)00428-1 [pii] AID - 10.1016/j.jpain.2010.03.013 [doi] PST - ppublish SO - J Pain. 2010 Dec;11(12):1356-67. doi: 10.1016/j.jpain.2010.03.013. Epub 2010 May 8.